Literature DB >> 1709161

Identification and molecular cloning of two new 30-kDa insulin-like growth factor binding proteins isolated from adult human serum.

M C Kiefer1, F R Masiarz, D M Bauer, J Zapf.   

Abstract

Three insulin-like growth factor binding proteins (IGFBP) with apparent molecular masses of 24, 28-30, and 30 kDa, nonreduced, have been isolated from human serum. The 15 NH2-terminal amino acids of the 24-kDa binding protein are identical with those of the 30-kDa BP. The apparent molecular mass of the latter is reduced to 24 kDa by N-glycanase, suggesting that the 30-kDa BP is the glycosylated form of the isolated 24-kDa BP. The complete amino acid sequences derived from the cloned cDNAs represent two new IGFBPs. They are tentatively termed IGFBP-4 and -5. The prepeptide sequences of BP-4 and -5 contain 27 and 21, the mature proteins 213 and 237 amino acids, respectively (Mr = 22,610 and 25,980). The NH2- and COOH-terminal thirds of BP-4 and -5 display pronounced homology to the other three human BPs. 16 of the 16-20 cysteines and 37 of the 213-289 amino acids (12.8-17.1%) are conserved in all five mature BPs. 10 amino acid positions located in the NH2-terminal region and shared by BP-1, -2, -3, and -5 are different in BP-4. These differences may account for the preferential affinity of BP-4 for IGF II. A most intriguing homology exists between the COOH-terminal quarter of the five IGFBPs, 10 repetitive domains of human thyroglobulin, a gastrointestinal tumor-associated antigen, and the invariant chain of the class II histocompatibility antigen. The cDNAs of five human IGFBPs are now available. They will allow their expression and production in sufficient quantities for in vivo studies to unravel their role in growth and metabolism.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1709161

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  11 in total

Review 1.  The insulin-like growth factor family of ligands, receptors, and binding proteins.

Authors:  R F Krywicki; D Yee
Journal:  Breast Cancer Res Treat       Date:  1992       Impact factor: 4.872

2.  Structural basis for the inhibition of insulin-like growth factors by insulin-like growth factor-binding proteins.

Authors:  Tomasz Sitar; Grzegorz M Popowicz; Igor Siwanowicz; Robert Huber; Tad A Holak
Journal:  Proc Natl Acad Sci U S A       Date:  2006-08-21       Impact factor: 11.205

3.  Identification of a family of low-affinity insulin-like growth factor binding proteins (IGFBPs): characterization of connective tissue growth factor as a member of the IGFBP superfamily.

Authors:  H S Kim; S R Nagalla; Y Oh; E Wilson; C T Roberts; R G Rosenfeld
Journal:  Proc Natl Acad Sci U S A       Date:  1997-11-25       Impact factor: 11.205

4.  Cataloging altered gene expression in young and senescent cells using enhanced differential display.

Authors:  M H Linskens; J Feng; W H Andrews; B E Enlow; S M Saati; L A Tonkin; W D Funk; B Villeponteau
Journal:  Nucleic Acids Res       Date:  1995-08-25       Impact factor: 16.971

5.  Tumor-associated calcium signal transducer 2 is required for the proper subcellular localization of claudin 1 and 7: implications in the pathogenesis of gelatinous drop-like corneal dystrophy.

Authors:  Mina Nakatsukasa; Satoshi Kawasaki; Kenta Yamasaki; Hideki Fukuoka; Akira Matsuda; Motokazu Tsujikawa; Hidetoshi Tanioka; Maho Nagata-Takaoka; Junji Hamuro; Shigeru Kinoshita
Journal:  Am J Pathol       Date:  2010-07-22       Impact factor: 4.307

6.  The Twisted gastrulation family of proteins, together with the IGFBP and CCN families, comprise the TIC superfamily of cysteine rich secreted factors.

Authors:  P Vilmos; K Gaudenz; Z Hegedus; J L Marsh
Journal:  Mol Pathol       Date:  2001-10

7.  Posttranslational regulation of insulin-like growth factor binding protein-4 in normal and transformed human fibroblasts. Insulin-like growth factor dependence and biological studies.

Authors:  C A Conover; M C Kiefer; J Zapf
Journal:  J Clin Invest       Date:  1993-03       Impact factor: 14.808

8.  Purification and molecular cloning of prostacyclin-stimulating factor from serum-free conditioned medium of human diploid fibroblast cells.

Authors:  T Yamauchi; F Umeda; M Masakado; M Isaji; S Mizushima; H Nawata
Journal:  Biochem J       Date:  1994-10-15       Impact factor: 3.857

9.  Intravenously injected insulin-like growth factor (IGF) I/IGF binding protein-3 complex exerts insulin-like effects in hypophysectomized, but not in normal rats.

Authors:  J Zapf; C Hauri; E Futo; M Hussain; J Rutishauser; C A Maack; E R Froesch
Journal:  J Clin Invest       Date:  1995-01       Impact factor: 14.808

Review 10.  Insulin-Like Growth Factor Binding Protein-5 in Physiology and Disease.

Authors:  Cumming Duan; John B Allard
Journal:  Front Endocrinol (Lausanne)       Date:  2020-03-03       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.